Filed: 2/14/2024ACC: 0001013594-24-000191
📋 What this filing means
LION POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 29 equity positions with a total reported market value of $199.86M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
29
Positions
$199.86M
Total AUM (reported)
18.59M
Total Shares
Allocation by class
COM$133.73M66.9%
RUSSELL 2000 ETF$33.12M16.6%
COM NEW$25.80M12.9%
COM CL A$2.29M1.1%
COM PAR $.01$2.18M1.1%
SPONSORED ADR$1.13M0.6%
CL A ORD SHS$833.6K0.4%
Portfolio Concentration
Top 3$167.57M83.8%
4–10$21.47M10.7%
11–25$10.56M5.3%
Rest$267.1K0.1%
Top 3 weight
83.8%
Top 10 weight
94.6%
Voting Authority Distribution
Total shares with voting rights: 18.59M
Sole
Full voting authority
18.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole29
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings29
Rows:
SEMTECH CORP
SOLEShares5.08M
TypeSH
Market value$111.26M
55.67%
Sole
5.08M
Shared
0.00
None
0.00
ISHARES TR
SOLEShares165K
TypeSH
Market value$33.12M
16.57%
Sole
165K
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
SOLEShares2.13M
TypeSH
Market value$23.20M
11.61%
Sole
2.13M
Shared
0.00
None
0.00
ARDELYX INC
SOLEShares1.15M
TypeSH
Market value$7.14M
3.57%
Sole
1.15M
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares1.65M
TypeSH
Market value$2.76M
1.38%
Sole
1.65M
Shared
0.00
None
0.00
HARPOON THERAPEUTICS INC
SOLEShares228.90K
TypeSH
Market value$2.60M
1.30%
Sole
228.90K
Shared
0.00
None
0.00
BURGERFI INTERNATIONAL INC
SOLEShares2.75M
TypeSH
Market value$2.36M
1.18%
Sole
2.75M
Shared
0.00
None
0.00
KINIKSA PHARMACEUTICALS LTD
SOLEShares130.69K
TypeSH
Market value$2.29M
1.15%
Sole
130.69K
Shared
0.00
None
0.00
INSMED INC
SOLEShares70.33K
TypeSH
Market value$2.18M
1.09%
Sole
70.33K
Shared
0.00
None
0.00
BATTALION OIL CORPORATION
SOLEShares222.18K
TypeSH
Market value$2.14M
1.07%
Sole
222.18K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares82.42K
TypeSH
Market value$1.95M
0.97%
Sole
82.42K
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares110K
TypeSH
Market value$1.23M
0.62%
Sole
110K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares80K
TypeSH
Market value$1.13M
0.57%
Sole
80K
Shared
0.00
None
0.00
ENPHYS ACQUISITION CORP
SOLEShares78.13K
TypeSH
Market value$833.6K
0.42%
Sole
78.13K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares34.50K
TypeSH
Market value$745.5K
0.37%
Sole
34.50K
Shared
0.00
None
0.00
BLUEBIRD BIO INC
SOLEShares531.26K
TypeSH
Market value$733.1K
0.37%
Sole
531.26K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares78K
TypeSH
Market value$701.2K
0.35%
Sole
78K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares1M
TypePRN
Market value$670.7K
0.34%
Sole
1M
Shared
0.00
None
0.00
HUMACYTE INC
SOLEShares235K
TypeSH
Market value$667.4K
0.33%
Sole
235K
Shared
0.00
None
0.00
SERES THERAPEUTICS INC
SOLEShares340.76K
TypeSH
Market value$477.1K
0.24%
Sole
340.76K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares13.50K
TypeSH
Market value$398.5K
0.20%
Sole
13.50K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares42.50K
TypeSH
Market value$358.3K
0.18%
Sole
42.50K
Shared
0.00
None
0.00
LUMOS PHARMA INC
SOLEShares90.79K
TypeSH
Market value$288.7K
0.14%
Sole
90.79K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares14K
TypeSH
Market value$206.1K
0.10%
Sole
14K
Shared
0.00
None
0.00
AADI BIOSCIENCE INC
SOLEShares82.42K
TypeSH
Market value$166.5K
0.08%
Sole
82.42K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SEMTECH CORPSOLE | COM | 5.08M | SH | $111.26M 55.67% | 5.08M | 0.00 | 0.00 |
ISHARES TRSOLE | RUSSELL 2000 ETF | 165K | SH | $33.12M 16.57% | 165K | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCSOLE | COM NEW | 2.13M | SH | $23.20M 11.61% | 2.13M | 0.00 | 0.00 |
ARDELYX INCSOLE | COM | 1.15M | SH | $7.14M 3.57% | 1.15M | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 1.65M | SH | $2.76M 1.38% | 1.65M | 0.00 | 0.00 |
HARPOON THERAPEUTICS INCSOLE | COM NEW | 228.90K | SH | $2.60M 1.30% | 228.90K | 0.00 | 0.00 |
BURGERFI INTERNATIONAL INCSOLE | COM | 2.75M | SH | $2.36M 1.18% | 2.75M | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS LTDSOLE | COM CL A | 130.69K | SH | $2.29M 1.15% | 130.69K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 70.33K | SH | $2.18M 1.09% | 70.33K | 0.00 | 0.00 |
BATTALION OIL CORPORATIONSOLE | COM | 222.18K | SH | $2.14M 1.07% | 222.18K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 82.42K | SH | $1.95M 0.97% | 82.42K | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 110K | SH | $1.23M 0.62% | 110K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | SPONSORED ADR | 80K | SH | $1.13M 0.57% | 80K | 0.00 | 0.00 |
ENPHYS ACQUISITION CORPSOLE | CL A ORD SHS | 78.13K | SH | $833.6K 0.42% | 78.13K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 34.50K | SH | $745.5K 0.37% | 34.50K | 0.00 | 0.00 |
BLUEBIRD BIO INCSOLE | COM | 531.26K | SH | $733.1K 0.37% | 531.26K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 78K | SH | $701.2K 0.35% | 78K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.250% 3/0 | 1M | PRN | $670.7K 0.34% | 1M | 0.00 | 0.00 |
HUMACYTE INCSOLE | COM | 235K | SH | $667.4K 0.33% | 235K | 0.00 | 0.00 |
SERES THERAPEUTICS INCSOLE | COM | 340.76K | SH | $477.1K 0.24% | 340.76K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 13.50K | SH | $398.5K 0.20% | 13.50K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 42.50K | SH | $358.3K 0.18% | 42.50K | 0.00 | 0.00 |
LUMOS PHARMA INCSOLE | COM | 90.79K | SH | $288.7K 0.14% | 90.79K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 14K | SH | $206.1K 0.10% | 14K | 0.00 | 0.00 |
AADI BIOSCIENCE INCSOLE | COM | 82.42K | SH | $166.5K 0.08% | 82.42K | 0.00 | 0.00 |
Page 1 of 2